Hatch-Waxman Act : Legislative Changes in the 108th Congress Affecting Pharmaceutical Patents.
Discusses recent legislative and regulatory issues and developments impacting pharmaceutical patents. Covers general provisions of the Drug Price Competition and Patent Term Restoration Act of 1984, selected patent-related issues, a 2002 FTC report on generic drug entry prior to patent expiration, a...
| Corporate Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
[Place of publication not identified] :
[publisher not identified],
2004.
|
| Series: | U.S. Congressional Research.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
| Summary: | Discusses recent legislative and regulatory issues and developments impacting pharmaceutical patents. Covers general provisions of the Drug Price Competition and Patent Term Restoration Act of 1984, selected patent-related issues, a 2002 FTC report on generic drug entry prior to patent expiration, a 2003 FDA rule change regarding patent listing requirements, enactment of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, declaratory judgments, brand name generics, and patent settlement antitrust implications. |
|---|---|
| Item Description: | Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Nov. 2010). Reuse except for individual research requires license from ProQuest, LLC. CRS Report. Electronic resource. |
| Physical Description: | 1 online resource. |